我国生物医药创新发展及影响因素探析OA

Objective:This paper aims to identify the key factors influencing the innovative development of China's biopharmaceutical industry and to propose strategies for its innovation-driven growth.Methods:This study analyzed the number of investigational new drug(IND)and new drug application(NDA)filings and approvals of innovative drugs,the share of innovative drug sales,and out-licensing deals.Driving factors were further examined from the perspectives of scientific and technological program support,reform of the drug review and approval system,and medical insurance policies.Results:China's biopharmaceutical industry has gradually transitioned from"following"to"running alongside,"and is moving toward"leading"in some areas.Conclusion:Despite significant progress in biopharmaceutical innovation,sustained efforts in basic research,original innovation,interdisciplinary integration,application of emerging technologies,talent cultivation,and international cooperation are essential for China to achieve continuous innovation and contribute to global healthcare.